合成和评估粉素-美芬胺酸结合物作为针对结肠的前药物
Shraddha Chugh1, Mousmee Sharma2, Harish Mudila3
1Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India.
Therapeutic delivery
|March 18, 2024
概括
新的胺结合粉素前药物使得可以针对结肠输送梅芬胺酸. 激活需要特定的酶,证明了控制释放的潜力,以改善药物输送.
科学领域:
- 制药化学 制药化学 制药化学
- 药物输送系统 药物输送系统
背景情况:
- 开发针对结肠的药物输送系统对于治疗炎症疾病至关重要.
- 梅芬胺酸是一种非类固醇抗炎药物 (NSAID),需要有针对性的输送,以最大限度地减少系统性副作用.
研究的目的:
- 为了合成和表征胺结合氨酸的基于氨酸的前药物.
- 评估这些新型前药的结肠向释放特征和激活机制.
主要方法:
- 使用光谱光度测量来评估前药物激活.
- 通过ELISA测量了循环氧化酶-1 (COX-1) 和循环氧化酶-2 (COX-2) 的抑制.
- 使用扫描电子显微镜观察生理条件下的前药物行为.
主要成果:
- 前药在无酶模拟的胃和肠介质中表现出最小的激活.
- 在与胰腺素进行预化和随后与aminopeptidase在模拟肠道介质中的治疗后,观察到显著的前药物激活.
- 与酶相关的免疫吸收剂测定证实了对COX-1和COX-2的剂量依赖抑制.
结论:
- 与胺基结合的氨酸-美芬胺酸结合物显示出针对结肠的药物输送潜力.
- 释放机制是受控和酶依赖的,胰腺素发挥着关键作用.
- 这些发现表明,局部NSAID在结肠中的输送是一个有希望的方法.
相关概念视频
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
207
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
207
Drugs for Treatment of Ulcerative Colitis in IBD
139
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
139
Phase II Conjugation Reactions: Overview
196
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
196


